These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27518031)

  • 1. HER2-positive feline mammary carcinoma.
    Marques C; Correia J; Ferreira F
    Aging (Albany NY); 2016 Aug; 8(8):1574-5. PubMed ID: 27518031
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.
    Soares M; Ribeiro R; Najmudin S; Gameiro A; Rodrigues R; Cardoso F; Ferreira F
    Oncotarget; 2016 Apr; 7(14):17314-26. PubMed ID: 26909614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feline HER2 protein expression levels and gene status in feline mammary carcinoma: optimization of immunohistochemistry (IHC) and in situ hybridization (ISH) techniques.
    Soares M; Correia J; Rodrigues P; Simões M; de Matos A; Ferreira F
    Microsc Microanal; 2013 Aug; 19(4):876-82. PubMed ID: 23718944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12-CXCR4 axis in feline mammary carcinoma.
    Ferreira F
    Aging (Albany NY); 2017 Dec; 9(12):2457-2458. PubMed ID: 29232654
    [No Abstract]   [Full Text] [Related]  

  • 5. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
    Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
    J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
    Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
    J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
    Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
    Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.
    Soares M; Correia J; Peleteiro MC; Ferreira F
    Tumour Biol; 2016 Mar; 37(3):4053-64. PubMed ID: 26486327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination.
    Gibson HM; Veenstra JJ; Jones R; Vaishampayan U; Sauerbrey M; Bepler G; Lum L; Reyes J; Weise A; Wei WZ
    Cancer Immunol Res; 2015 Jul; 3(7):777-86. PubMed ID: 25711535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
    Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
    Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study.
    Ordás J; Millán Y; Dios R; Reymundo C; de Las Mulas JM
    BMC Cancer; 2007 Sep; 7():179. PubMed ID: 17880730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular based subtyping of feline mammary carcinomas and clinicopathological characterization.
    Soares M; Madeira S; Correia J; Peleteiro M; Cardoso F; Ferreira F
    Breast; 2016 Jun; 27():44-51. PubMed ID: 27212699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
    Seixas F; Pires MA; Lopes CA
    Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression.
    Timmermans-Sprang EP; Gracanin A; Mol JA
    BMC Cancer; 2015 Jul; 15():545. PubMed ID: 26205886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.
    De Maria R; Olivero M; Iussich S; Nakaichi M; Murata T; Biolatti B; Di Renzo MF
    Cancer Res; 2005 Feb; 65(3):907-12. PubMed ID: 15705889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors.
    Wang Q; Ding H; Wang H; Li P; Liu B; Zhang K
    Oncol Rep; 2015 Jan; 33(1):179-84. PubMed ID: 25354531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
    Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
    Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary mucinous carcinoma in the cat.
    Sarli G; Brunetti B; Benazzi C
    Vet Pathol; 2006 Sep; 43(5):667-73. PubMed ID: 16966443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
    Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
    Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.